Pharmaceutica Analytica Acta

Department of Pharmacognosy, Guilin University of Electronic Technology, Guilin, China

Biography

Daniel I.C. Wang is an Institute Professor at MIT and a prominent figure in biochemical engineering. He earned his Ph.D. in chemical engineering from the University of Pennsylvania in 1963, and both his B.S. and M.S. from MIT in 1959 and 1961, respectively. Wang has significantly contributed to the development of bioprocesses, particularly in the production of recombinant proteins and monoclonal antibodies, as well as in the design and optimization of bioreactors.

Wang was involved in establishing MIT's Bioprocess Engineering Center (BPEC), which was one of the first academic centers focusing on the intersection of biotechnology and engineering. He was a key player in the development of biopharmaceutical manufacturing, particularly at Biogen, where he served as an early scientific board member. His work helped shape the biotechnological industry, including optimizing microbial and mammalian cell systems for high-yield production.

In recognition of his contributions, Wang received numerous honors, including the Amgen Biochemical Engineering Award and the William H. Walker Award from the American Institute of Chemical Engineers. He was a member of both the National Academy of Engineering and the American Academy of Arts and Sciences. In 2014, MIT renamed a prestigious biotechnology lectureship in his honor, and the American Institute of Chemical Engineers created an annual award in his name to celebrate excellence in biochemical engineering

Publications

• Opinion Article   
  Blockchain Technology: A Catalyst for Transparency in Pharmaceutical Supply Chains
  Author(s): Daniel Wang*
  
  

  DOI: 10.35248/2153-2435.24.15.777

  HTML PDF